Marla S. Persky
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marla S. Persky
Marla S. Persky is recorded as Chairman at Xeris Biopharma Holdings, Inc. (XERS). Xeris Biopharma Holdings, Inc. reported in an 8-K filed June 30, 2026 that Marla S. Persky was appointed Lead Independent Director, effective July 1, 2026. Xeris Biopharma Holdings, Inc. reported in an 8-K filed July 8, 2024 that Marla S. Persky was appointed Chairperson of the Board, effective August 1, 2024. Xeris Biopharma Holdings, Inc. reported in an 8-K filed June 5, 2024 that Marla S. Persky was appointed Class III director, effective June 5, 2024.
“In connection with this leadership structure, the Board designated Marla S. Persky as the Company’s Lead Independent Director, as of July 1, 2026.”
“Marla S. Persky, currently a Class III director of the Company, has been appointed by the Board to serve as the Chairperson of the Board, effective as of the Transition Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-01–present
-
Current
2024-08-01–present
-
2021-01-01–2024-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xeris Biopharma Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- John P. Shannon CEO, Board Member
- John Shannon CEO, Chairman, COO, Board Member
- Steven M. Pieper CFO
- Kevin McCulloch COO
- Beth P. Hecht General Counsel
- Dawn Halkuff Board Member
- Jeffrey W. Sherman Board Member
- John H. Johnson Board Member
- John Johnson Board Member
- Nerissa Kreher Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.